Trials / Conditions / Metastatic Sarcomatoid Renal Cell Carcinoma

Metastatic Sarcomatoid Renal Cell Carcinoma

6 registered clinical trials studyying Metastatic Sarcomatoid Renal Cell Carcinoma — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy NCT07218692	City of Hope Medical Center	Phase 2
Recruiting	Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatm NCT07128680	City of Hope Medical Center	Phase 1
Recruiting	Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Ki NCT06866262	University of Michigan Rogel Cancer Center	Phase 1 / Phase 2
Recruiting	CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer NCT06399419	Osel, Inc.	Phase 1
Active Not Recruiting	CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cance NCT05122546	City of Hope Medical Center	Phase 1
Recruiting	Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted NCT03866382	National Cancer Institute (NCI)	Phase 2